-+ 0.00%
-+ 0.00%
-+ 0.00%

SCILEX HOLDING COMPANY ANNOUNCES THAT THE U.S. FDA HAS ACKNOWLEDGED THE SUBMISSION OF OUR SUPPLEMENTAL NEW DRUG APPLICATION FOR ELYXYB® IN ACUTE PAIN INDICATION

Reuters·01/22/2025 13:00:02

Please log in to view news